. [7] [8] [9] 따라 서 수술 전 근치 절제가능성 여부의 판정이 매우 중요하다. (Table 2) . (Table 4) . 4 1. Systemic chemotherapy followed by concurrent chemoradiation therapy -Pancreatic cancer is thought to be systemic disease; therefore, systemic chemotherapy should be applied first -Use of radiosenstizing drug in phase of radiotherapy therapy for enhancing local control -Avoid toxicity potentially derived from full-dose concurrent chemoradiation therapy 2. Concurrent chemoradiation therapy -Pancreatic cancer is thought to be systemic disease; therefore, systemic chemotherapy should be applied first -Control both systemic and local disease -Shorten the duration of preoperative therapy -Concurrent neoadjuvant chemoradiation does not appear to increase the risk of pancreatectomy -Tolerable cytotoxicity 3. Chemotherapy only -Pancreatic cancer is thought to be systemic disease; therefore, systemic chemotherapy should be applied first 
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